CERo Therapeutics Holdings Inc
CERO7.660USD
-0.015-0.20%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
1.98MMarket Cap
LossP/E TTM
CERo Therapeutics Holdings Inc
7.660
-0.015-0.20%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
12.49%-4.45M
-60.30%-1.54M
-109.25%-2.76M
-70.53%-3.54M
-253.60%-5.08M
---960.77K
---1.32M
---2.07M
---1.44M
Net income from continuing operations
-122.03%-5.11M
153.11%671.89K
-183.08%-4.23M
-17.02%-2.45M
5.69%-2.30M
---1.27M
---1.49M
---2.09M
---2.44M
Operating gains losses
-32.87%76.29K
-15.87%96.38K
-1.33%113.86K
-0.94%114.30K
-1.51%113.64K
--114.56K
--115.39K
--115.39K
--115.39K
Other non-cash items
102.40%349.43K
3.99%188.25K
1.74%183.11K
3.70%179.32K
9.13%172.64K
--181.03K
--179.97K
--172.93K
--158.20K
Change in working capital
92.22%-70.41K
1051.78%1.24M
2084.61%927.67K
1723.51%576.39K
-236.50%-905.37K
---130.12K
--42.46K
---35.50K
--663.27K
-Change in prepaid expenses
45.06%-289.71K
138.65%59.53K
889.92%264.61K
444.47%258.84K
-685.32%-527.38K
---154.01K
--26.73K
---75.14K
--90.10K
-Change in other current liabilities
-427.13%-299.69K
540.67%815.77K
2755.60%535.42K
14677.26%849.42K
-64.12%91.61K
---185.12K
---20.16K
---5.83K
--255.35K
Cash from non-recurring investing activities
Cash from operating activities
12.49%-4.45M
-60.30%-1.54M
-109.25%-2.76M
-70.53%-3.54M
-253.60%-5.08M
---960.77K
---1.32M
---2.07M
---1.44M
Investing cash flow
Cash from non-current investing activities
Net cash flow from investing activities
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
-11.67%6.32M
--1.49M
249176700.00%2.49M
357.39%2.59M
138428.47%7.16M
--0.00
---1.00
--566.51K
--5.17K
Net cash flow from debt Issuance/repayment
----
--6.66M
---150.90K
-124.67%-149.34K
--408.05K
--0.00
--0.00
--605.23K
--0.00
Net cash flow from common stock issuance/repurchase
8837.74%1.23M
--670.51K
--1.90M
--2.24M
--13.73K
----
--0.00
--0.00
--0.00
Net cash flow from preferred stock issuance/repurchase
-26.14%4.99M
--538.40K
--703.96K
--502.00K
--6.76M
----
--0.00
--0.00
--0.00
Proceeds from stock option exercised by employees
---395.00K
----
--0.00
-100.00%0.00
-100.00%0.00
---1.00
--0.00
--600.00
--5.17K
Proceeds from issuance of warrants
--500.18K
---38.00K
--38.00K
----
----
----
----
----
----
Net cash flow from other financing activities
----
-633938500.00%-6.34M
100.00%0.00
100.00%0.00
---19.71K
--1.00
---1.00
---39.32K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-11.67%6.32M
--1.49M
249176700.00%2.49M
357.39%2.59M
138428.47%7.16M
--0.00
---1.00
--566.51K
--5.17K
Net cash flow
Beginning cash balance
-4.37%3.33M
69.56%4.34M
18.83%4.61M
3.13%5.56M
-48.98%3.48M
--2.56M
--3.88M
--5.39M
--6.82M
Current period cash flow changes
-9.69%1.88M
94.47%-53.14K
79.76%-266.82K
37.25%-946.08K
245.14%2.08M
---960.77K
---1.32M
---1.51M
---1.43M
Ending cash balance
-6.36%5.20M
167.97%4.29M
69.56%4.34M
18.83%4.61M
3.13%5.56M
--1.60M
--2.56M
--3.88M
--5.39M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
